Nevertheless, concomitant DM was a significant predictor of worse outcomes in patients with high tumoral CEBPD expression (UBUC p = .0046; UTUC p = .0187) (Figure 6A3,7). Here, CEBPD is linked to renal pelvis/ureter urothelial carcinoma.